UNSPSC 51286602: Ftivazide

This classification denotes an antitubercular agent with the molecular formula C14H13N3O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 40Q4C3O4V0, chemically known as isonicotinic acid, vanillylidenehydrazide but more generally known as ftivazide, which bears US NIH Compound Identifier 5355297. European Medicines Agency schedules Ftivazide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07821MIG.

The term FTIVAZIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 19 1975, List 5). FTIVAZIDE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. SMILES: O(C1=C/C(=C/NNC(=O)C2CCNCC2)C=CC1=O)C.

UNSPSC 51286602 Ftivazide, a Commodity code, represents pharmaceutical products supplied to state and local health agencies through piggyback and direct-procurement vehicles. State and local governments buy specific pharmaceutical formulations—in recent activity, antibiotics such as doxycycline and ciprofloxacin, as well as naloxone and related public-health pharmaceuticals—typically through competitive bidding or cooperative purchasing consortia. Issuing bodies include state health departments and county health authorities; the Illinois Department of Public Health and Seminole County, Florida appear as recent buyers. These jurisdictions procure on fixed-term contracts with renewal options, requiring vendors to meet E-Verify, drug-free workplace, and insurance compliance standards, and often requiring quarterly or regular deliveries to specified health facilities or warehouses.

Recent activity centers in Illinois and Florida. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract to Chartwell Rx LLC through the MMCAP Infuse consortium on August 28, 2026 (Invitation for Bid 26482DPHPREPDB53392) for doxycycline hyclate 100mg and ciprofloxacin hydrochloride 500mg tablets under a 12-month initial term with two renewal options. Seminole County, Florida solicited 1,900 units of naloxone and 800 safe drug deactivation systems annually through IFB 60459723LAS (posted June 30, 2026, response deadline July 26, 2023) with quarterly deliveries to the Seminole County Community Health Building; the procurement was potentially FEMA-funded and subject to federal environmental compliance requirements. Both procurements emphasize lowest-price responsive bidding and vendor responsibility vetting.